Alignment Healthcare, Inc. Stock Price, News & Analysis

Alignment Healthcare (NASDAQ: ALHC) reported strong Q1 2025 financial results, exceeding expectations across key metrics. Revenue grew 47.5% YoY to $926.9 million, while Medicare Advantage membership increased 31.7% to 217,500 members. The company posted an adjusted EBITDA of $20.2 million, though it recorded a net loss of $9.4 million. The medical benefits ratio was 88.4%. Based on strong performance, ALHC raised its 2025 guidance midpoints for membership (228,000-233,000), revenue ($3,770M-$3,815M), and adjusted EBITDA ($38M-$60M). Additionally, the company announced a CFO transition, with Thomas Freeman stepping down after 8 years to become Strategic Advisor to the CEO, replaced by Jim Head, formerly CFO at Claritev.

Alignment Healthcare (NASDAQ: ALHC) has announced its upcoming participation at the BofA Securities Healthcare Conference. The presentation is scheduled for Wednesday, May 14, at 2:20 p.m. PDT.

Interested parties can access both the live webcast and replay of the presentation through Alignment's investor relations website at https://ir.alignmenthealth.com/.

Alignment Healthcare (NASDAQ: ALHC) has announced two key leadership appointments to enhance its AI-enabled Medicare Advantage platform. Dr. Arta Bakshandeh has been named President of AVA®, the company's proprietary platform that utilizes 200+ data sources and 13,000+ attributes for personalized healthcare insights. Aly Duzich has been promoted to Chief Experience Officer to optimize member experience.

AVA platform leverages trusted AI to improve senior health outcomes and quality of care while reducing costs. The company has grown to over 200,000 health plan members since its IPO in March 2021. Both appointments aim to strengthen Alignment's care management and service delivery approach, integrating technology with compassionate care for seniors.

Alignment Healthcare (NASDAQ: ALHC) has scheduled the release of its first quarter 2025 financial results for Thursday, May 1, 2025, after market close. The company will host a conference call at 5 p.m. EDT to discuss the results.

Investors and interested parties can access a live audio webcast of the conference call through the company's investor relations website at https://ir.alignmenthealth.com/. The webcast replay will be available for approximately 12 months after the call.

Sutter Health and Alignment Healthcare (NASDAQ: ALHC) have renewed their strategic partnership, ensuring continued in-network access to Sutter's healthcare network for Alignment's Medicare Advantage members in Northern California. The agreement covers members enrolled in Sutter Advantage HMO and My Choice PPO health plans across 10 counties.

Sutter Health plans to expand its healthcare infrastructure starting in 2025, including:

• 27 new ambulatory care sites
• 27 urgent care centers
• 22 ambulatory surgery centers

The collaboration combines Sutter Health's provider network with Alignment's care model and AVA® technology platform, focusing on serving high-risk individuals with chronic conditions. The partnership spans across Placer, Sacramento, San Francisco, San Joaquin, San Mateo, Santa Clara, Santa Cruz, Sonoma, Stanislaus, and Yolo counties.

Alignment Healthcare (NASDAQ: ALHC) has announced its upcoming participation in two major healthcare conferences in March 2025. The company will present at the Leerink Global Healthcare Conference on Tuesday, March 11, at 3:40 p.m. EDT, followed by a presentation at the KeyBanc Capital Markets Healthcare Forum on Wednesday, March 19, at 10:30 a.m. EDT.

Both presentations will be accessible via webcast, with replays available on Alignment's investor relations website at ir.alignmenthealth.com.

Alignment Healthcare (ALHC) reported strong growth in its Q4 and full-year 2024 results. Health plan membership reached 189,100 as of December 31, 2024, marking a 58.6% increase year-over-year. The company achieved its first full year of positive adjusted EBITDA as a public company.

Q4 2024 highlights include total revenue of $701.2 million, up 50.7% year-over-year, with a medical benefits ratio of 87.5%. The company recorded an adjusted EBITDA of $1.4 million, despite a net loss of $(31.1) million.

For full-year 2024, total revenue reached $2,703.6 million, increasing 48.3% year-over-year, with an adjusted EBITDA of $1.3 million and a net loss of $(128.1) million. Looking ahead, ALHC provided 2025 revenue guidance of $3.72-3.78 billion, projecting 37.6-39.6% growth, with adjusted EBITDA expected between $35-60 million.

Alignment Healthcare (NASDAQ: ALHC) has scheduled its fourth quarter and full-year 2024 financial results announcement for Thursday, February 27, 2025, after market close. The company will host a conference call at 5 p.m. EST to discuss the results.

A live audio webcast will be accessible at ir.alignmenthealth.com. The webcast replay will be available for approximately 12 months after the call for on-demand listening.

Alignment Healthcare (NASDAQ: ALHC) reported significant growth with 209,900 members as of January 1, representing a 35% year-over-year increase in health plan membership. The company projects 225,000 to 231,000 members by December 31, 2025, indicating 22-25% growth from year-end 2024.

The company reaffirmed its full-year 2024 guidance and expressed confidence in achieving consensus adjusted EBITDA of approximately $40 million in 2025. Additionally, Dawn Maroney has been promoted to President of Alignment Healthcare, where she will oversee day-to-day operations.

Notable achievements include having 98% of members enrolled in 4-star or above rated plans for 2025, maintaining a 5-star rating for North Carolina and Nevada HMO contracts, and earning 4.5 stars for California PPO and 4 stars for California HMO in 2025.